News
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
1dOpinion
MedPage Today on MSNHow Fast Is Too Fast for FDA Drug Review?In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...
Mike Davis previously worked as clinical team leader at the FDA’s Division of Psychiatry before serving as chief medical ...
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
FDA Commissioner Marty Makary reportedly initiated a brief request last week to decline approval of a rare disease drug ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
The Food and Drug Administration commissioner repeatedly said patients should rely on guidance from their doctors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results